Vaccines
- Ref-No.Technology
- 02-00116New viral packaging cell line
- 02-00158
Cyclic di-Nucleotides as adjuvants
- 02-00160Hexosylceramides as adjuvants
- 02-00280Innovative lipopeptide-conjugates as mucosal adjuvants - BPPcysPep-MPEG
- 02-00361
Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
- 02-00369
Biodynamers enhance drug delivery
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00527New Class of Bacterial Capsule Polymerases for Cost-Effective Synthesis of Glycoconjugate Vaccines
- 15-00601
Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis
- 23-00074Treating C9orf72 ALS/FTD with active vaccination
- 32-00135
Novel broad spectrum SARS-CoV-2 Vaccine Gene